Add news
March 2010
April 2010
May 2010June 2010July 2010
August 2010
September 2010October 2010
November 2010
December 2010
January 2011
February 2011March 2011April 2011May 2011June 2011July 2011August 2011September 2011October 2011November 2011December 2011January 2012February 2012March 2012April 2012May 2012June 2012July 2012August 2012September 2012October 2012November 2012December 2012January 2013February 2013March 2013April 2013May 2013June 2013July 2013August 2013September 2013October 2013November 2013December 2013January 2014February 2014March 2014April 2014May 2014June 2014July 2014August 2014September 2014October 2014November 2014December 2014January 2015February 2015March 2015April 2015May 2015June 2015July 2015August 2015September 2015October 2015November 2015December 2015January 2016February 2016March 2016April 2016May 2016June 2016July 2016August 2016September 2016October 2016November 2016December 2016January 2017February 2017March 2017April 2017May 2017June 2017July 2017August 2017September 2017October 2017November 2017December 2017January 2018February 2018March 2018April 2018May 2018June 2018July 2018August 2018September 2018October 2018November 2018December 2018January 2019February 2019March 2019April 2019May 2019June 2019July 2019August 2019September 2019October 2019November 2019December 2019January 2020February 2020March 2020April 2020May 2020June 2020July 2020August 2020September 2020October 2020November 2020December 2020January 2021February 2021
News Every Day |

Oxford Covid vaccine to be tested on children for the first time

A child receives a Covid-19 (coronavirus) vaccine
The study aims to learn more about children’s immune response to Covid-19 (Picture: Rex/Shutterstock)

The coronavirus vaccine developed by Oxford University and AstraZeneca is set to be tested on children in a new clinical trial.

Researchers will use 300 volunteers to assess whether the jab will produce a strong immune response in children aged between six and 17.

The Oxford jab is one of three to have been approved for use in adults in the UK, along with those from Pfizer/BioNTech and Moderna.

Professor of paediatric infection and immunity, and chief investigator of the vaccine trial Andrew Pollard said: ‘While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.’

The first immunisations under the trial will take place this month, with up to 240 children receiving the vaccine and the others receiving a control meningitis jab.

Earlier this week, England’s deputy chief medical officer said ‘several’ trials were under way to develop vaccines that are safe and effective in children.

A bottle containing the Oxford / AstraZeneca Covid-19 vaccine is pictured at a temporary vaccination centre in Helsinki, Finland, on February 12, 2021.
Severe illness or death among children with Covid-19 can happen but is rare (Picture: REX)

Professor Jonathan Van-Tam told ITV News: ‘It is perfectly possible that we will have some licensed children’s vaccines for Covid-19 by the end of the year.’

The Royal College of Paediatrics and Child Health has said there is evidence Covid-19 can cause death and severe illness in children, but that this is rare.

It said: ‘In children, the evidence is now clear that Covid-19 is associated with a considerably lower burden of morbidity and mortality compared to that seen in the elderly.

‘There is also some evidence that children may be less likely to acquire the infection.

‘The role of children in transmission, once they have acquired the infection, is unclear, although there is no clear evidence that they are any more infectious than adults.’

The University of Oxford said theirs was the first trial in the 6-17 age group. It said other trials had begun but only measuring efficacy in those aged 16 and 17.

Paediatrician and clinician-scientist at the Oxford Vaccine Group Rinn Song said: ‘The Covid-19 pandemic has had a profound negative impact on the education, social development and emotional well-being of children and adolescents, beyond illness and rare severe disease presentations.

‘It is therefore important to collect data on the safety and the immune response to our coronavirus vaccine in these age groups, so that they could potentially benefit from inclusion in vaccination programs in the near future.’

Get in touch with our news team by emailing us at webnews@metro.co.uk.

For more stories like this, check our news page.





Read also

Gauci unaware of excess COVID-19 vaccines going to people not on list

Who is Ellie Kemper?

Oklahoma residents can apply for individual assistance from winter storms




News, articles, comments, with a minute-by-minute update, now on Today24.pro



Today24.pro — latest news 24/7. You can add your news instantly now — here
News Every Day

RIPPING Fish Off Pylons! Bonefish, Sheepshead & Tripletail Catch & Cook